To assess the prognostic value of smaller than expected early Crown-rump length (CRL) to predict the occurrence of subsequent first trimester miscarriage in women with singleton pregnancy conceived by in vitro fertilisation treatment with or without intracytoplasmic sperm injection (IVF/ICSI). Methods: A retrospective observational study of prospectively collected data of first trimester intra-uterine singleton pregnancies after an IVF/ICSI fresh cycle was conducted at a tertiary centre where embryonic transfer is performed at the cleavage stage.
Objectives: Tubal ectopic pregnancy (EP) is a common, potentially life threatening complication. The gold standard of diagnosis is transvaginal ultrasound (TVUS). Serum beta human chorionic gonadotrophin (hCG) may be used as an aid in the diagnosis and management of EPs is. It is well established that a beta hCG threshold for visualisation of an intrauterine pregnancy with TVUS is 1000-1500 IU/L. The aim of this study was to assess the proportion of women with EPs diagnosed on ultrasound scan have a hCG level less than 1000-1500IU/L. Methods: This was a retrospective cohort study based on an audit carried out in two Units (Peterborough City Hospital, UK-Unit A and Addenbrooke's Hospital, Cambridge, UK-Unit B). The audit included cases collected over 12 months. Student's t-test and Chi 2 statistics were used as appropriate. Results: A total of 87 cases were identified (42 in Unit A and 45 in Unit B) with 63 cases subjected to detailed analysis. A total of 24 (38.1%) women had a beta hCG below 1500 IU/L (8 in unit A and 16 in unit B) with 19 patients having a hCG level below 1000 IU/L at US diagnosis of ectopic pregnancy. Conclusions: The collected data from two distinct units indicates that in up to 38.1% of cases with histologically confirmed ectopic pregnancies, the hCG at US diagnosis was below 1500 IU/L. Therefore, we postulate that TVUS should be the first line investigation in women with early pregnancy problems. To assess the health benefits of this approach, an appropriately powered randomised controlled study of US scan at first presentation versus hCG monitoring and US scan once the threshold of 1000-1500 IU/L has been achieved should be designed. 
